This follows an earlier statement by health authorities that said the country is fully prepared to respond to any emerging health developments, including those related to Ebola
The UAE’s public health situation remains stable, with no indication of concern within the country, according to the National Emergency Crisis and Disaster Management Authority (NCEMA).
The announcement followed a high-level meeting involving NCEMA, the Ministry of Health and Prevention (MoHAP), emergency management officials, and strategic partners to review the latest regional and international developments related to the Ebola outbreak and assess the country’s preparedness measures.
During the meeting, officials examined current epidemiological trends and evaluated existing response plans to ensure the UAE remains ready to address any emerging public health challenges.
The review comes as an Ebola outbreak continues in the Democratic Republic of the Congo, with cases also reported in Uganda. In response, the UAE has advised its citizens to avoid non-essential travel to Uganda, the Democratic Republic of the Congo, and South Sudan.
The latest assessment follows a statement issued by UAE health authorities on May 19, which affirmed the country’s readiness to respond to any health developments, including those related to Ebola, citing the strength of its surveillance, monitoring, and rapid response systems.
Medical experts in the UAE have also reassured residents that the risk to the public remains extremely low. Doctors emphasised that Ebola does not spread through casual contact in public places such as airports, shopping centres, or public transport networks, while encouraging travellers to stay informed and follow recommended health precautions.
Several countries have introduced precautionary travel measures in response to the outbreak. Bahrain recently suspended the entry of foreign travellers arriving from South Sudan, the Democratic Republic of the Congo, and Uganda, becoming the first GCC country to implement such restrictions.
Jordan has also temporarily suspended entry for travellers arriving from the three affected countries.
Meanwhile, the World Health Organization has identified three experimental treatments for the Bundibugyo strain of Ebola currently circulating in the region. These include MBP134 developed by Mapp Biopharmaceutical, Regeneron’s maftivimab, and Gilead Sciences’ antiviral drug remdesivir.
The WHO has recommended that these treatments, along with potential vaccine candidates, undergo clinical trials to gather further evidence on their effectiveness against the Bundibugyo strain, for which there is currently no approved vaccine or specific treatment.
UAE authorities reiterated that public health monitoring systems remain active and are continuously reviewed to ensure the country maintains the highest standards of preparedness and protection.
